We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
-9.08%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$23.2B
AUM Growth
-$3.45B
Cap. Flow
-$7.17B
Cap. Flow %
-30.93%
Top 10 Hldgs %
18.24%
Holding
1,260
New
101
Increased
295
Reduced
128
Closed
108
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFLX icon
101
Netflix
NFLX
$292B
$32.7M 0.14%
1,869,710
-136,490
-7% -$3.03M
CTXS
102
DELISTED
Citrix Systems Inc
CTXS
$32.6M 0.14%
335,436
+129,543
+63% +$12.9M
SLB icon
103
SLB Ltd
SLB
$77.8B
$32.6M 0.14%
910,444
+24,096
+3% +$1M
DHR.PRB
104
DELISTED
Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B
DHR.PRB
$32.5M 0.14%
+24,529
New +$34.6M
CVS icon
105
CVS Health
CVS
$137B
$32.2M 0.14%
347,158
+8,628
+3% +$842K
KKR.PRC
106
DELISTED
KKR & Co. Inc. 6.00% Series C Mandatory Convertible Preferred Stock
KKR.PRC
$31.9M 0.14%
544,842
+3,678
+0.7% +$245K
UPS icon
107
United Parcel Service
UPS
$97.6B
$31.9M 0.14%
174,491
+4,672
+3% +$852K
ORCL icon
108
Oracle
ORCL
$331B
$31.4M 0.14%
448,854
+91,323
+26% +$6.69M
BAC.PRL icon
109
Bank of America Series L
BAC.PRL
$3.95B
$31.2M 0.13%
25,901
+34
+0.1% +$41.7K
EW icon
110
Edwards Lifesciences
EW
$47.6B
$30.8M 0.13%
324,170
-15,520
-5% -$1.61M
AMZN icon
111
PUT
Amazon
AMZN
$2.5T
$30.8M 0.13%
+290,200
New +$36.3M
ISRG icon
112
Intuitive Surgical
ISRG
$121B
$30.7M 0.13%
153,056
+3,293
+2% +$773K
SBUX icon
113
Starbucks
SBUX
$118B
$30.6M 0.13%
400,320
+8,679
+2% +$667K
VRTX icon
114
Vertex Pharmaceuticals
VRTX
$121B
$30.4M 0.13%
107,891
+2,904
+3% +$777K
ADP icon
115
Automatic Data Processing
ADP
$100B
$30.2M 0.13%
143,975
+3,877
+3% +$850K
NVO
116
Novo Nordisk
NVO
$216B
$29.9M 0.13%
536,986
+83,254
+18% +$4.62M
INTU icon
117
Intuit
INTU
$81.1B
$29.3M 0.13%
76,060
+12,096
+19% +$5.01M
A icon
118
Agilent Technologies
A
$39.1B
$29.2M 0.13%
245,759
+6,617
+3% +$814K
PAYC icon
119
Paycom
PAYC
$6.78B
$28.5M 0.12%
101,907
-8,325
-8% -$2.46M
SMH icon
120
PUT
VanEck Semiconductor ETF
SMH
$67.6B
$28.5M 0.12%
+280,000
New +$32.5M
XME icon
121
PUT
State Street SPDR S&P Metals & Mining ETF
XME
$4.05B
$28.3M 0.12%
+653,000
New +$35.5M
DUK icon
122
Duke Energy
DUK
$102B
$27.7M 0.12%
257,954
+6,947
+3% +$764K
LRCX icon
123
Lam Research
LRCX
$382B
$27.7M 0.12%
648,950
-139,630
-18% -$6.65M
QQQ icon
124
CALL
Invesco QQQ Trust
QQQ
$455B
$27.6M 0.12%
98,300
DFS
125
DELISTED
Discover Financial Services
DFS
$27.2M 0.12%
287,959
+4,451
+2% +$476K

Similar funds

Calamos Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Calamos Advisors held 1,260 positions worth $23.2B, down 13% from $26.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Calamos Advisors withdrew a net $7.17B in Q2 2022, closing 108 positions and reducing 128 holdings. Its most notable exit was Avantor, Inc. Series A Mandatory Convertible Preferred Stock, an estimated $111M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Calamos Advisors opened a new position in Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B worth $32.5M.

  • Calamos Advisors's largest Q2 2022 buy was Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B: 24,529 shares worth $32.5M.
  • Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $285M increase.
  • Calamos Advisors's biggest Q2 2022 reduction was Bank of America, cutting an estimated $24.1M.
  • Calamos Advisors fully exited Avantor, Inc. Series A Mandatory Convertible Preferred Stock in Q2 2022, selling an estimated $111M.
  • Calamos Advisors's ten largest holdings make up 18% of its $23.2B portfolio in Q2 2022.
  • Calamos Advisors opened 101 new positions and closed 108 in Q2 2022.
  • Calamos Advisors's portfolio value fell 13% quarter-over-quarter to $23.2B.

Based on Calamos Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.